miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-30b-5p | ||||
miRNA Stemloop AC | MI0000441 | ||||
miRNA Stemloop ID | hsa-mir-30b | ||||
Sequence | uguaaacauccuacacucagcu | ||||
TTD Target(s) Regulated by This miRNA | Platelet-derived growth factor receptor beta (PDGFRB) | Successful Target | Target Info | [1] | |
Apoptosis regulator Bcl-2 (BCL-2) | Successful Target | Target Info | [2] | ||
Cellular tumor antigen p53 (TP53) | Clinical trial Target | Target Info | [3] | ||
DNA [cytosine-5]-methyltransferase 1 (DNMT1) | Clinical trial Target | Target Info | [4] | ||
Endothelial plasminogen activator inhibitor (SERPINE1) | Clinical trial Target | Target Info | [5] | ||
Catalase (CAT) | Clinical trial Target | Target Info | [6] | ||
Notch-1 receptor (NOTCH1) | Clinical trial Target | Target Info | [3] | ||
Delta-like protein 4 (DLL4) | Clinical trial Target | Target Info | [7] | ||
Beclin-1 (BECN1) | Literature-reported Target | Target Info | [8] | ||
Eukaryotic initiation factor 5A2 (EIF5A2) | Literature-reported Target | Target Info | [9] | ||
Muscleblind-like protein 1 (MBNL2) | Literature-reported Target | Target Info | [10] | ||
G1/S-specific cyclin-E2 (CCNE2) | Literature-reported Target | Target Info | [11] | ||
Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Target Info | [12] | ||
Suppressor of cytokine signaling 1 (SOCS1) | Literature-reported Target | Target Info | [13] | ||
Protein(s) Regulated by This miRNA | B-cell CLL/lymphoma 9 protein | Regulated Protein | [14] | ||
B-cell lymphoma 6 protein | Regulated Protein | [13] | |||
Collagen triple helix repeat-containing protein 1 | Regulated Protein | [16] | |||
Eukaryotic translation initiation factor 2 subunit 1 | Regulated Protein | [17] | |||
Homeobox protein Hox-A1 | Regulated Protein | [18] | |||
Homeobox protein SIX1 | Regulated Protein | [19] | |||
Muscleblind-like protein 1 | Regulated Protein | [10] | |||
Muscleblind-like protein 3 | Regulated Protein | [10] | |||
Ras GTPase-activating protein nGAP | Regulated Protein | [21] | |||
Transcriptional regulator ERG | Regulated Protein | [22] | |||
Ubiquitin-like protein ATG12 | Regulated Protein | [23] | |||
Zinc finger protein SNAI1 | Regulated Protein | [24] | |||
References | |||||
REF 1 | Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor . Rheumatology (Oxford). 2013 Nov;52(11):1963-72. | ||||
REF 2 | NF-B-mediated miR-30b regulation in cardiomyocytes cell death by targeting Bcl-2. Mol Cell Biochem. 2014 Feb;387(1-2):135-41. | ||||
REF 3 | Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol. 2014 Jan;25(1):92-104. | ||||
REF 4 | Decreased miR-30b-5p expression by DNMT1 methylation regulation involved in gastric cancer metastasis. Mol Biol Rep. 2014 Sep;41(9):5693-700. | ||||
REF 5 | Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.Genes Dev. 2011 Oct 15;25(20):2173-86. | ||||
REF 6 | MicroRNA-30b-mediated regulation of catalase expression in human ARPE-19 cells. PLoS One. 2012;7(8):e42542. | ||||
REF 7 | The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood. 2012 Dec 13;120(25):5063-72. | ||||
REF 8 | EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 2012 May 2;31(9):2207-21. | ||||
REF 9 | MiR-30b suppresses tumor migration and invasion by targeting EIF5A2 in gastric cancer. World J Gastroenterol. 2015 Aug 21;21(31):9337-47. | ||||
REF 10 | miR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL. Int J Mol Sci. 2016 Jan 29;17(2). pii: E182. | ||||
REF 11 | Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells. PLoS One. 2012;7(2):e31422. | ||||
REF 12 | Bone morphogenetic protein-2 decreases microRNA-30b and microRNA-30c to promote vascular smooth muscle cell calcification. J Am Heart Assoc. 2012 Dec;1(6):e003905. | ||||
REF 13 | Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells. J Immunol. 2012 Apr 1;188(7):3042-52. | ||||
REF 14 | miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/-catenin/BCL9 pathway.Cancer Res. 2014 Mar 15;74(6):1801-13. | ||||
REF 15 | Downregulation of inflammatory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor cells. J Immunol. 2012 Apr 1;188(7):3042-52. | ||||
REF 16 | microRNA-30b inhibits cell invasion and migration through targeting collagen triple helix repeat containing 1 in non-small cell lung cancer.Cancer Cell Int. 2015 Sep 17;15:85. | ||||
REF 17 | A microRNA-mediated decrease in eukaryotic initiation factor 2 promotes cell survival during PS-341 treatment.Sci Rep. 2016 Feb 22;6:21565. | ||||
REF 18 | miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer.Biochem Biophys Res Commun. 2017 Apr 1;485(2):506-512. | ||||
REF 19 | miR-30b regulates migration and invasion of human colorectal cancer via SIX1.Biochem J. 2014 May 15;460(1):117-25. | ||||
REF 20 | miR-30-5p Regulates Muscle Differentiation and Alternative Splicing of Muscle-Related Genes by Targeting MBNL. Int J Mol Sci. 2016 Jan 29;17(2). pii: E182. | ||||
REF 21 | Temporal analysis of reciprocal miRNA-mRNA expression patterns predicts regulatory networks during differentiation in human skeletal muscle cells.Physiol Genomics. 2015 Mar;47(3):45-57. | ||||
REF 22 | miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.Oncogene. 2014 May 8;33(19):2495-503. | ||||
REF 23 | Compromised autophagy by MIR30B benefits the intracellular survival of Helicobacter pylori. Autophagy. 2012 Jul 1;8(7):1045-57. | ||||
REF 24 | MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.Int J Cancer. 2012 May 1;130(9):2044-53. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.